Profile
| Metric | Value |
|---|---|
| Full Name | DaVita Inc. |
| Ticker | NYSE: DVA |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | |
| Website | davita.com |
| Employees | 76,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $104.74 | |
| Price, 1D Change | -1.04% | |
| Market Cap | $7B | |
| - | ||
| PE Ratio | 10.78 | |
| Beta | 0.48 | |
| Revenue | $13B | |
| Revenue, 1Y Change | +5.56% | |
| EPS | $10.73 | |
| EPS, 1Y Change | +44.57% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $10.73 | |
| EPS Estimate | $10.67 | |
| EPS Est. Change | -0.51% | |
| Revenue | $12.82B | |
| Revenue Estimate | $13.51B | |
| Revenue Est. Change | +5.45% | |
| Current Price | $104.74 | |
| Price Target | - | $138.00 |
| Price Tgt. Change | - | +31.75% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.86 | $7.42 | -5.58% | |
| $9.73 | $10.73 | +10.28% | |
| $10.67 | N/A | -0.51% | |
| $12.74 | N/A | +18.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.00B | $12.14B | +1.14% | |
| $12.76B | $12.82B | +0.44% | |
| $13.51B | N/A | +5.45% | |
| $13.96B | N/A | +8.89% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -36.46% | |
| Price, 3Y | +32.53% | |
| Market Cap, 1Y | -44.30% | |
| Market Cap, 3Y | +3.49% | |
| Revenue, 1Y | +5.56% | |
| Revenue, 3Y | +10.30% | |
| EPS, 1Y | +44.57% | |
| EPS, 3Y | +20.56% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $104.74 | |
| SMA 200 | $132.04 | |
| SMA 200 vs Price | +26.07% | |
| SMA 50 | $116.47 | |
| SMA 50 vs Price | +11.19% | |
| Beta | 0.48 | |
| ATR | $3.00 | |
| 14-Day RSI | 29.31 | |
| 10-Day Volatility | 33.15% | |
| 1-Year Volatility | 30.91% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $12.82B | |
| EPS | $10.73 | |
| Gross Profit | $4.22B | |
| Gross Margin | 32.91% | |
| Operating Profit | $1.95B | |
| Operating Margin | 15.25% | |
| Net Income | $1.25B | |
| Net Margin | 7.31% | |
| EBITDA | $2.72B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 77.99 | |
| Current Ratio | 1.26 | |
| Quick Ratio | 1.21 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 1.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 10.78 | |
| PS Ratio | 0.56 | |
| PB Ratio | -12.93 | |
| EV/EBITDA | 7.32 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $121.12M | |
| Cash & Equivalents | $794.93M | |
| Total Assets | $17.97B | |
| Current Assets | $3.75B | |
| Total Liabilities | $15.88B | |
| Current Liabilities | $2.97B | |
| Total Debt | $12.07B | |
| Short Term Debt | $681.28M | |
| Accounts Payable | $547.20M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $10.86B | |
| Operating Expenses | $2.26B | |
| Cost Of Goods Sold | $8.60B | |
| SG&A | $1.54B | |
| D&A | $723.86M | |
| Interest Expense | $0.00 | |
| Income Tax | $279.66M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $2.02B | |
| CFI | -$771.43M | |
| CFF | -$816.94M | |
| Capex | $555.44M | |
| Free Cash Flow | $1.47B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Barclays | → | |
| Barclays | → | |
| B of A Securities | → | |
| Barclays | → | |
| Truist Securities | → | |
| Barclays | → | |
| Barclays | → | |
| Truist Securities | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
Screeners with DVA
FAQ
What is the ticker symbol for DaVita Inc.?
The ticker symbol for DaVita Inc. is NYSE:DVA
Does DaVita Inc. pay dividends?
No, DaVita Inc. does not pay dividends
What sector is DaVita Inc. in?
DaVita Inc. is in the Healthcare sector
What industry is DaVita Inc. in?
DaVita Inc. is in the Medical Care Facilities industry
What country is DaVita Inc. based in?
DaVita Inc. is headquartered in United States
When did DaVita Inc. go public?
DaVita Inc. initial public offering (IPO) was on October 31, 1995
Is DaVita Inc. in the S&P 500?
Yes, DaVita Inc. is included in the S&P 500 index
Is DaVita Inc. in the NASDAQ 100?
No, DaVita Inc. is not included in the NASDAQ 100 index
Is DaVita Inc. in the Dow Jones?
No, DaVita Inc. is not included in the Dow Jones index
When was DaVita Inc. last earnings report?
DaVita Inc.'s most recent earnings report was on October 29, 2025
When does DaVita Inc. report earnings?
The next expected earnings date for DaVita Inc. is February 12, 2026
Data Sources & References
- DVA Official Website www.davita.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/927066/000092706625000165/0000927066-25-000165-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706625000012/0000927066-25-000012-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
- DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva